Patient characteristics
Patients, no. | 110 |
| Sex, M/F | 59/51 |
| Median age, y (range) | 34 (0.7-64) |
| FAB classification, no. of patients | |
| AML-M4 | 99* |
| AML-M2 | 7 |
| AML-M1 | 3 |
| Unclassified | 1 |
| Study, no. of patients | |
| LAME-91 | 23 |
| ALFA-9000 | 26 |
| BGMT-87 | 12 |
| BGMT-91 | 12 |
| GOELAM-01 | 10 |
| GOELAM-02 | 27 |
| Median marrow blast percentage (range) | 64 (22-100) |
| Median WBC, × 109/L (range) | 44 (3-390) |
| 75% percentile upper limit | 89 |
| 90% percentile upper limit | 173 |
| 95% percentile upper limit | 222 |
| Median platelet count, × 109/L (range) | 46 (6-215) |
| 25% percentile lower limit | 30 |
| 10% percentile lower limit | 19 |
| 5% percentile lower limit | 17 |
| Median Hb count, g/L (range) | 90 (49-150) |
| 25% percentile lower limit | 77 |
| 10% percentile lower limit | 60 |
| 5% percentile lower limit | 58 |
Patients, no. | 110 |
| Sex, M/F | 59/51 |
| Median age, y (range) | 34 (0.7-64) |
| FAB classification, no. of patients | |
| AML-M4 | 99* |
| AML-M2 | 7 |
| AML-M1 | 3 |
| Unclassified | 1 |
| Study, no. of patients | |
| LAME-91 | 23 |
| ALFA-9000 | 26 |
| BGMT-87 | 12 |
| BGMT-91 | 12 |
| GOELAM-01 | 10 |
| GOELAM-02 | 27 |
| Median marrow blast percentage (range) | 64 (22-100) |
| Median WBC, × 109/L (range) | 44 (3-390) |
| 75% percentile upper limit | 89 |
| 90% percentile upper limit | 173 |
| 95% percentile upper limit | 222 |
| Median platelet count, × 109/L (range) | 46 (6-215) |
| 25% percentile lower limit | 30 |
| 10% percentile lower limit | 19 |
| 5% percentile lower limit | 17 |
| Median Hb count, g/L (range) | 90 (49-150) |
| 25% percentile lower limit | 77 |
| 10% percentile lower limit | 60 |
| 5% percentile lower limit | 58 |
WBC indicates white blood cell count; Hb, hemoglobin.
Including 77 AML-M4eo in the FAB classification.